Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Minoshima

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer DiseaseAnand K Deo, Soo Borson, Jeanne M Link, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 31, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Science Translational Medicine|January 15, 2016
Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunctionJames S Meabon, Bertrand R Huber, Donna J Cross, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Toward a Universal Readout for <sup>18</sup>F-Labeled Amyloid Tracers: The CAPTAINs StudyGérard N Bischof, Peter Bartenstein, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid QuantificationAnne M Smith, Nancy A Obuchowski, Norman L Foster, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementiasLisa Mosconi, Wai H Tsui, Karl Herholz, et al.
Annals of Nuclear Medicine|September 25, 2013
Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort studyKengo Ito, Etsuro Mori, Hidenao Fukuyama, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer DiseaseAnand K Deo, Soo Borson, Jeanne M Link, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 31, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Science Translational Medicine|January 15, 2016
Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunctionJames S Meabon, Bertrand R Huber, Donna J Cross, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Toward a Universal Readout for <sup>18</sup>F-Labeled Amyloid Tracers: The CAPTAINs StudyGérard N Bischof, Peter Bartenstein, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid QuantificationAnne M Smith, Nancy A Obuchowski, Norman L Foster, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementiasLisa Mosconi, Wai H Tsui, Karl Herholz, et al.
Annals of Nuclear Medicine|September 25, 2013
Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort studyKengo Ito, Etsuro Mori, Hidenao Fukuyama, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Pageof 16